Trioar
PrivateLast Round
Grant
Jul 6, 2026
Est. Valuation
$56.9M
Total Funding Raised
$53.16M
Company Overview
Trioar is a biotechnology company that develops next-generation antibody-based therapeutics, including antibody-drug conjugates (ADCs) and immuno-oncology treatments, using its proprietary TROCAD™ and TROSIG™ platform technologies.
Sector
Enterprise Software
Verticals
AR/VR Experiences, Marketing, Event Management, Content Creation
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Trioar Comparables
Compare Trioar with similar companies based on industry and business-model similarity.
Trioar Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 6, 2026 | ||||
| Series B | Aug 28, 2025 | ||||
| Series B | Jul 17, 2025 | ||||
| Series A | May 23, 2023 | ||||
| Pre Seed | Feb 24, 2022 | ||||
Angel | May 1, 2021 |
Trioar Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CKD Venture Capital | Series B |
| Shinhan Venture Investment | Series B |
| KB Investment | Series B, Pre Seed, Series A |
| Woori Venture Partners Co., Ltd. | Series B |
| Kiwoom Investment | Series B, Series A |
| Hyundai Technology Investment | Series B |
| Jin & Investment Partners | Series B |
Trioar Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Trioar's valuation, stock price, and market status.
Is Trioar a public or private company?
Trioar is a private company.
What is the current stock price of Trioar?
Trioar is a private company with no public stock price. No recent secondary market data is available.
How much is Trioar worth (valuation)?
Valuation information for Trioar is not publicly available.
Can I buy Trioar stock?
Trioar shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Trioar's last funding round?
Trioar's most recent funding round was Series B on August 28, 2025.
Who are the main investors in Trioar?
Key investors in Trioar include LSK Investment, LSK Investment, Woori Venture Partners.
Will Trioar IPO soon?
No public IPO plans have been announced for Trioar.
How can I track Trioar secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Trioar's secondary market activity and sign up for updates.